Consultancy PWW has developed pharmaceutical company GlaxoSmithKline’s (GSK) new research and development facility, Immersive Intelligent Manufacturing.
The new 697m2 “smart space” is designed to demonstrate how “state-of-the-art systems and technologies can be combined in a manufacturing line and environment”, according to the consultancy.
Workshops, manufacturing and collaboration areas
The IIM facility is being used to accelerate technology adoption within GSK, and includes internal and external spaces that are interconnected. The “sandpit”, for instance, encompasses workshops, manufacturing and collaboration areas.
Other design features include a changing room complete with augmented reality lab attire instruction and compliance, which indicates whether the user is dressed correctly or not.
Colour has been used to improve the functionality of the facility by identifying different areas within it, as well as being incorporated in the signage, graphics and user interfaces.
“Show the art of possible”
PWW’s design allows for flexible use of the facility, which is considered necessary due to the range of outputs and research carried out there.
Remote working is also possible through the use of technology that helps to control and visualise the manufacturing data.
Head of GSK’s IIM project, Patrick Hyett, says: “We wanted to build a facility we can point to and show the art of the possible.”